Assessment of Pharmacokinetics and Bioavailability of Carbon-14 ([14C])-Labelled Oxytocin
Status:
Withdrawn
Trial end date:
2017-08-31
Target enrollment:
Participant gender:
Summary
The current study is designed as a phase I multiple dose study to evaluate the
pharmacokinetics and bioavailability of [14C]-labelled oxytocin in healthy women.